Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 25 Neoplasms 12 Stomach Neoplasms 10 Endometrial Neoplasms 10 Lung Neoplasms 9 Lymphatic Metastasis 7 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Vulvar Neoplasms 3 Sarcoma 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Colorectal Neoplasms 3 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skull Base Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Osteosarcoma 2 Margins of Excision 2 Lymphedema 2 Hypoparathyroidism 2 Giant Cell Tumor of Bone 2

Interventions

Cyclophosphamide 115 Dexamethasone 70 fludarabine phosphate 57 Cytarabine 56 fludarabine 52 Rituximab 51 Peripheral Blood Stem Cell Transplantation 40 Etoposide 40 Gemcitabine 39 Lenalidomide 38 pembrolizumab 33 Radiotherapy 33 Busulfan 33 Filgrastim 32 Carboplatin 31 Methotrexate 30 Cyclosporine 29 Cisplatin 29 Bortezomib 29 Mycophenolic Acid 28 Melphalan 28 venetoclax 27 Paclitaxel 26 Whole-Body Irradiation 24 Antilymphocyte Serum 23 Temozolomide 22 Granulocyte Colony-Stimulating Factor 20 Calcium Dobesilate 20 Bevacizumab 20 Tacrolimus 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Recurrence × Indocyanine Green × Clear all

NCT02920216 2022-03-31

SALVADS-Fluo

Institut de Cancérologie de Lorraine

Phase NA Completed

Head and Neck Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡